NEOMED Library: PPC IV Literature Review Requirements (self-directed learning assignment): Rheumatology Topics

Osteoarthritis

Lumiracoxib versus celecoxib for treating osteoarthritis
Celecoxib versus diclofenac for treating arthritis
Celecoxib versus omeprazole and diclofenac for treating arthritis
Glucosamine/chondroitin versus chondroitin for treating osteoarthritis
Glucosamine/chondroitin versus glucosamine for treating osteoarthritis
Glucosamine versus chondroitin for treating osteoarthritis
Glucosamine/chondroitin versus celecoxib for treating osteoarthritis
Meriva/glucosamine versus chondroitin/glucosamine for treating osteoarthritis
Photo-activated platelet-rich plasma injections vs hyaluronic acid injections for treating osteoarthritis
Chondroitin sulfate versus celecoxib for treating osteoarthritis

Comparing infliximab to adalimumab for treating rheumatoid arthritis
Comparing infliximab to etanercept for treating rheumatoid arthritis
Comparing methotrexate to rituximab for the treatment of rheumatoid arthritis
Comparing methotrexate to rituximab with methotrexate for the treatment of rheumatoid arthritis
Celecoxib vs. diclofenac for treating arthritis
Tocilizumab vs. methotrexate for treating rheumatoid arthritis
Celecoxib vs. omeprazole and diclofenac for treating arthritis
Comparing etanercept with methotrexate to an etanercept monotherapy for treating rheumatoid arthritis
Treating rheumatoid arthritis with disease-modifying antirheumatic drugs with or without ginger

Alendronate vs. risedronate for treating osteoporosis
Teriparatide and denosumab versus teriparatide alone for treating osteoporosis
Teriparatide and denosumab versus denosumab alone for treating osteoporosis
Ibandronate versus risedronate for treating osteoporosis
Romosozumab versus alendronate for preventing fractures in women with osteoporosis
Ibandronate versus alendronate for treating osteoporosis